We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest News

News

Evaluation of UNIarray® for Infectious Disease Diagnostics

Protagen and Mikrogen close their collaboration agreement for the identification of typical autoantibody signatures in infectious diseases.
News

TGen and Geisinger Health System Announce Strategic Partnership to Shape Future of Personalized Medicine

Obesity and diabetes focus of first study
News

Hundreds of Genes Distinguish Patients Likely to Survive Advanced Melanoma

Study lays groundwork for personalized medicine in patients with advanced skin cancer
News

Estrogen can Reduce Stroke Damage by Inactivating Protein

Data from researchers at Medical College of Georgia suggets that Estrogen can halt stroke damage by inactivating a tumor-suppressing protein known to prevent many cancers.
News

Graceway Pharmaceuticals Acquires Early-stage Dermatological Molecules from Pfizer

Graceway acquires worldwide commercial rights for three investigational dermatological molecules from Pfizer.
News

Engineering Innovative Solutions for 21st Century Medicine

The Wellcome Trust and the Engineering and Physical Sciences Research Council (EPSRC) have announced joint funding for four new Centres of Excellence in Medical Engineering to transform the future of healthcare.
News

Nanostart holding Lumiphore Announces Major new Commercialization Partnership

Lumiphore technology to be used in diagnostic tests from Brahms AG and its subsidiary Cezanne.
News

Parkinson's Disease Society Joins Forces with Healthy Interactions to Launch new Education Programme

The Conversation Map™ tool programme to address the needs of people at all stages of Parkinson’s as well as the needs of their families and carers.
News

Exiqon partners with MedTrust Online to Promote Molecular Oncology Diagnostic Services to Oncologists

Exiqon will provide a comprehensive suite of oncology molecular diagnostics services to MedTrust Online's Oncocentric oncology portal.
News

Celldex Acquires Exclusive Rights to Immune-stimulatory Molecules from Amgen

FMS-like tyrosine kinase 3 ligand and CD40 ligand among assets to be utilized in cancer and anti-inflammatory immunotherapies.
Advertisement